1. Home
  2. APLT vs JUNE Comparison

APLT vs JUNE Comparison

Compare APLT & JUNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • JUNE
  • Stock Information
  • Founded
  • APLT 2016
  • JUNE 1998
  • Country
  • APLT United States
  • JUNE Singapore
  • Employees
  • APLT N/A
  • JUNE N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • JUNE
  • Sector
  • APLT Health Care
  • JUNE
  • Exchange
  • APLT Nasdaq
  • JUNE Nasdaq
  • Market Cap
  • APLT 80.3M
  • JUNE 83.2M
  • IPO Year
  • APLT 2019
  • JUNE 2024
  • Fundamental
  • Price
  • APLT $0.52
  • JUNE $9.46
  • Analyst Decision
  • APLT Buy
  • JUNE
  • Analyst Count
  • APLT 7
  • JUNE 0
  • Target Price
  • APLT $6.10
  • JUNE N/A
  • AVG Volume (30 Days)
  • APLT 1.6M
  • JUNE 80.2K
  • Earning Date
  • APLT 05-08-2025
  • JUNE 05-10-2025
  • Dividend Yield
  • APLT N/A
  • JUNE N/A
  • EPS Growth
  • APLT N/A
  • JUNE N/A
  • EPS
  • APLT N/A
  • JUNE N/A
  • Revenue
  • APLT N/A
  • JUNE $2,903,179.00
  • Revenue This Year
  • APLT N/A
  • JUNE N/A
  • Revenue Next Year
  • APLT $2,426.33
  • JUNE N/A
  • P/E Ratio
  • APLT N/A
  • JUNE N/A
  • Revenue Growth
  • APLT N/A
  • JUNE N/A
  • 52 Week Low
  • APLT $0.43
  • JUNE $2.75
  • 52 Week High
  • APLT $10.62
  • JUNE $9.90
  • Technical
  • Relative Strength Index (RSI)
  • APLT 43.47
  • JUNE N/A
  • Support Level
  • APLT $0.52
  • JUNE N/A
  • Resistance Level
  • APLT $0.62
  • JUNE N/A
  • Average True Range (ATR)
  • APLT 0.05
  • JUNE 0.00
  • MACD
  • APLT 0.01
  • JUNE 0.00
  • Stochastic Oscillator
  • APLT 23.19
  • JUNE 0.00

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About JUNE Junee Limited Ordinary Shares

Junee Ltd is a holding company that operates through its subsidiary. It is engaged in providing design, fit-out, repair, and maintenance services for commercial and residential buildings. The design services include both the consultation with its staff and the actual design work. Fit-out works include installing protective materials to cover floors or walls, installing or constructing partition walls, installing switches, power outlets, telephone wiring, computer outlet covers, and other electrical and wiring works. Repair and maintenance works include, among other things, replacement of fixtures and fittings, repair and maintenance of cupboards and shelves, and repainting walls and ceilings. Geographically, the company derives all of its revenue from its customers in Hong Kong.

Share on Social Networks: